Match tier
Listed
Presence
Current · Arkansas
Last published
2026
Sources
OpenAlex · ORCID
Refreshed
2026-10-08
H
Hannah E. Shaw
Role not yet determined Is this you? Add your title
Also affiliated: University of Maryland, Baltimore (2024); United States Department of Justice (2024); Drug Enforcement Administration (2024)
4 h-index
8 pubs
31 cited
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Hannah E. Shaw investigates the pharmacological effects and abuse liability of novel psychoactive substances. Her research involves animal models, primarily mice, to study drug-induced behaviors such as locomotion and respiratory depression, as well as the potential for dependence and withdrawal. Recent work has examined the effects of synthetic cannabinoid receptor agonists, arylcyclohexylamines, and fentanyl analogues, assessing their interactions with opioid systems and the efficacy of antagonists like naloxone.
Shaw's publications also explore the neurocognitive effects of various drugs, including those with phencyclidine-like properties and their implications for psychosis-like symptoms. She has investigated the interoceptive effects of lysergamides and the impact of psychedelics on opioid consumption and withdrawal. Her collaborators include William E. Fantegrossi, Brenda M. Gannon, Jeffery H. Moran, and Marina Avram, all from the University of Arkansas for Medical Sciences, with whom she has co-authored multiple publications. Shaw's work contributes to understanding drug mechanisms and potential therapeutic interventions.
Metrics
- h-index: 4
- Publications: 8
- Citations: 31
Selected Publications
-
Interoceptive effects of N1-substituted lysergamides in rats: Role of agonist affinity at 5-hydroxytryptamine receptors and in vivo metabolism to lysergic acid diethylamide (2026)
-
Effects of Psychedelics Lysergic Acid Diethylamide and R (–)-2,5-Dimethoxy-4-Iodoamphetamine on Oral Opioid Consumption and Naloxone-Precipitated Withdrawal in Male C57Bl/6J Mice (2026)
-
Effects of psychostimulants on locomotor activity in the BTBR T+ Itpr3tf/J mouse: implications for comorbid autism spectrum disorder and attention deficit hyperactivity disorder (2025)
-
Effects of orally self-administered furanyl fentanyl and acryl fentanyl in mice: antinociception, dependence and withdrawal, and defense of consumption (2025)
-
Synthetic cannabinoid receptor agonists exacerbate fentanyl-elicited respiratory depression and confer resistance to naloxone rescue in mice (2025)
-
Phencyclidine-Like Abuse Liability and Psychosis-Like Neurocognitive Effects of Novel Arylcyclohexylamine Drugs of Abuse in Rodents (2024)
-
Balancing Therapeutic Efficacy and Safety of MDMA and Novel MDXX Analogues as Novel Treatments for Autism Spectrum Disorder (2023)
Collaboration Network
Top Collaborators
William E. Fantegrossi
University of Arkansas Medical Center
7 shared publications
In database
- Balancing Therapeutic Efficacy and Safety of MDMA and Novel MDXX Analogues as Novel Treatments for Autism Spectrum Disorder
- Phencyclidine-Like Abuse Liability and Psychosis-Like Neurocognitive Effects of Novel Arylcyclohexylamine Drugs of Abuse in Rodents
- Synthetic cannabinoid receptor agonists exacerbate fentanyl-elicited respiratory depression and confer resistance to naloxone rescue in mice
- Effects of orally self-administered furanyl fentanyl and acryl fentanyl in mice: antinociception, dependence and withdrawal, and defense of consumption
- Effects of psychostimulants on locomotor activity in the BTBR T+ Itpr3tf/J mouse: implications for comorbid autism spectrum disorder and attention deficit hyperactivity disorder
Showing 5 of 7 shared publications
Brenda M. Gannon
University of Arkansas for Medical Sciences
3 shared publications
In database
- Phencyclidine-Like Abuse Liability and Psychosis-Like Neurocognitive Effects of Novel Arylcyclohexylamine Drugs of Abuse in Rodents
- Effects of orally self-administered furanyl fentanyl and acryl fentanyl in mice: antinociception, dependence and withdrawal, and defense of consumption
- Effects of Psychedelics Lysergic Acid Diethylamide and R (–)-2,5-Dimethoxy-4-Iodoamphetamine on Oral Opioid Consumption and Naloxone-Precipitated Withdrawal in Male C57Bl/6J Mice
Marina Avram
Arkansas Department of Agriculture
3 shared publications
In database
- Synthetic cannabinoid receptor agonists exacerbate fentanyl-elicited respiratory depression and confer resistance to naloxone rescue in mice
- Effects of orally self-administered furanyl fentanyl and acryl fentanyl in mice: antinociception, dependence and withdrawal, and defense of consumption
- Interoceptive effects of N1-substituted lysergamides in rats: Role of agonist affinity at 5-hydroxytryptamine receptors and in vivo metabolism to lysergic acid diethylamide
Harpreet Kaur
Oncolytics Biotech (Canada) (CA)
2 shared publications
- Balancing Therapeutic Efficacy and Safety of MDMA and Novel MDXX Analogues as Novel Treatments for Autism Spectrum Disorder
- Effects of psychostimulants on locomotor activity in the BTBR T+ Itpr3tf/J mouse: implications for comorbid autism spectrum disorder and attention deficit hyperactivity disorder
Stephen A. Fagot
University of Arkansas for Medical Sciences
2 shared publications
In database
- Balancing Therapeutic Efficacy and Safety of MDMA and Novel MDXX Analogues as Novel Treatments for Autism Spectrum Disorder
- Effects of psychostimulants on locomotor activity in the BTBR T+ Itpr3tf/J mouse: implications for comorbid autism spectrum disorder and attention deficit hyperactivity disorder
Theresa M. Carbonaro
Drug Enforcement Administration
2 shared publications
In database
- Phencyclidine-Like Abuse Liability and Psychosis-Like Neurocognitive Effects of Novel Arylcyclohexylamine Drugs of Abuse in Rodents
- Interoceptive effects of N1-substituted lysergamides in rats: Role of agonist affinity at 5-hydroxytryptamine receptors and in vivo metabolism to lysergic acid diethylamide
Jeffery H. Moran
Arkansas Department of Agriculture
2 shared publications
In database
- Synthetic cannabinoid receptor agonists exacerbate fentanyl-elicited respiratory depression and confer resistance to naloxone rescue in mice
- Effects of orally self-administered furanyl fentanyl and acryl fentanyl in mice: antinociception, dependence and withdrawal, and defense of consumption
Sedat Karabulut
University of Windsor (CA)
1 shared publication
- Balancing Therapeutic Efficacy and Safety of MDMA and Novel MDXX Analogues as Novel Treatments for Autism Spectrum Disorder
James W. Gauld
University of Windsor (CA)
1 shared publication
- Balancing Therapeutic Efficacy and Safety of MDMA and Novel MDXX Analogues as Novel Treatments for Autism Spectrum Disorder
Kalee N. Holloway
University of Arkansas for Medical Sciences
1 shared publication
In database
- Balancing Therapeutic Efficacy and Safety of MDMA and Novel MDXX Analogues as Novel Treatments for Autism Spectrum Disorder
Dylan R. Patel
University of Maryland, Baltimore
1 shared publication
In database
- Phencyclidine-Like Abuse Liability and Psychosis-Like Neurocognitive Effects of Novel Arylcyclohexylamine Drugs of Abuse in Rodents
Lauren R. Fitzgerald
University of Maryland, Baltimore
1 shared publication
In database
- Phencyclidine-Like Abuse Liability and Psychosis-Like Neurocognitive Effects of Novel Arylcyclohexylamine Drugs of Abuse in Rodents
Chad R. Johnson
University of Maryland, Baltimore (US)
1 shared publication
- Phencyclidine-Like Abuse Liability and Psychosis-Like Neurocognitive Effects of Novel Arylcyclohexylamine Drugs of Abuse in Rodents
J S James
University of Arkansas for Medical Sciences
1 shared publication
In database
- Synthetic cannabinoid receptor agonists exacerbate fentanyl-elicited respiratory depression and confer resistance to naloxone rescue in mice
Jessica Thrush
University of Arkansas for Medical Sciences
1 shared publication
In database
- Synthetic cannabinoid receptor agonists exacerbate fentanyl-elicited respiratory depression and confer resistance to naloxone rescue in mice
Similar Researchers
Based on overlapping research topics
Theresa M. Carbonaro
University of Arkansas for Medical Sciences
Pharmacological Effects and Toxicity Studies
Neuroscience and Neuropharmacology Research
Animal, Disease Models
William E. Fantegrossi
University of Arkansas for Medical Sciences
Pharmacological Effects and Toxicity Studies
Neuroscience and Neuropharmacology Research
Animal, Disease Models
Jennifer E. Naylor
University of Arkansas for Medical Sciences
Pharmacological Effects and Toxicity Studies
Neuroscience and Neuropharmacology Research
Animal, Disease Models
Lirit N. Franks
University of Arkansas for Medical Sciences
Pharmacological Effects and Toxicity Studies
Neuroscience and Neuropharmacology Research
Animal, Disease Models
Justin R. Nickell
University of Arkansas for Medical Sciences
Pharmacological Effects and Toxicity Studies
Neuroscience and Neuropharmacology Research
Substance Abuse Treatment and Outcomes
Scott M. Apana
University of Arkansas for Medical Sciences
Pharmacological Effects and Toxicity Studies
Neuroscience and Neuropharmacology Research
Animal, Disease Models